Browse the full record of transactions filed by KARINE LIGNEL, Administratrice. Officer active across 2 companies, notably Oncodesign Precision Medicine S.A.. Cumulatively, 6 disclosures have been published. Total volume traded: €1.1m. The latest transaction was disclosed on 12 December 2022 — Acquisition. Regulator: AMF. All data is openly available.
Karine Lignel is a Board Member and Deputy Chief Executive Officer at Oncodesign and Oncodesign Precision Medicine S.A. In this role, she participates in the strategic decisions of the board and contributes to the governance of the companies. Karine brings her expertise in research and innovation, which is essential for guiding Oncodesign in its growth initiatives.